The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma - A report from the German cooperative liver tumour studies HB 89 and HB 94

European Journal of Pediatric Surgery

Volumn 12, Issue 4, 2002, Pages 255-261

  Fuchs, J ^a   Rydzynski, J ^a   Hecker, H ^a   Mildenberger, H ^a   Burger D ^a   Harms, D ^a   Schweinitz, D V ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Atypical anatomical liver resection; Chemotherapy; Hepatoblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ADOLESCENT; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; FEMALE; FOLLOW UP; GERMANY; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; INFANT; LIVER METASTASIS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; SURGICAL TECHNIQUE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DATA INTERPRETATION, STATISTICAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HEPATOBLASTOMA; HUMANS; IFOSFAMIDE; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; PREOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 0036696535     PISSN: 09397248     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34484     Document Type: Conference Paper

References (24)

1. Achilleos O, Buist L, Kelly D, Raafat F, McMaster P, Mayer A, Buckels JA. Unresectable hepatic tumors in childhood and the role of liver transplantation. J Pediatr Surg 1996; 31: 1563-1567
2. Bader P, Fuchs J, Wenderoth M, v. Schweinitz D, Niethammer D, Beck J. Alterated expression of resistance associated genes in hepatoblastoma xenografts incorporated in mice following treatment with doxorubicin or cisplatin. Anticancer Res 1998; 18: 3127-3132
3. Brown J, Perilongo G, Shafford E, Keeling J, Prichard J, Brock P, Dicks-Mireaux C, Phillips A, Vos A, Plaschkes J. Pretreatment prognostic factors for children with hepatoblastoma - Results from the International Society of Pediatric Oncology (SIOP) Study SIOPEL 1. Eur J Cancer 2000; 36: 1418-1425
4. Exelby P, Filler R, Grosfeld J. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey - 1974. J Pediatr Surg 1975; 10: 337
5. Filler R, Ehrlich P, Grennberg M. Preoperative chemotherapy in hepatoblastoma. Surgery 1992; 110: 519-522
6. Fuchs J, Bode U, v. Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H. Analysis of treatment efficiency and toxicity of carboplatin and etoposide in combination with radical surgery in advanced or recurrent childhood hepatoblastoma: A report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94. Klin Pädiatr 1999; 211: 305-309
7. Fuchs J, Rydzynski J, v. Schweinitz D, Bode U, Harms D, Weinel P, Hecker H, Mildenberger H. The treatment of hepatoblastoma - A report from the German Cooperative Pediatric Liver Tumor Study HB 94. Med Pediatr Oncol 2000; 35: 254
8. Ishak K, Glunz P. Hepatoblastoma and hepatocarcinoma in infancy and childhood. Cancer 1967; 20: 396-422
9. Kalbfleisch J, Prentice R. The Statistical Analysis of Failure Time Data. New York: John Wiley and Sons, 1980
10. King D, Ortega J, Campell J. The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. J Pediatr Surg 1991; 26: 1074-1981
11. Oldhafer K, Fuchs J, Steinhoff G, Mildenberger H. Ausgedehnte Leberresektionen bei Kleinkindern im Kreislaufstillstand und unter Low-flow-Kreislaufbedingungen an der Herz-Lungen-Maschine. Chirurg 2000; 71: 692-695
12. Reynolds M. Conversion of unresectable to resectable hepatoblastoma and long-term follow-up study. World J Surg 1995; 19: 814-816
13. Reynolds M, Douglass E, Finegold M. Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg 1992; 27: 1080-1084
14. Schmidt D, Harms D, Lang W. Primary malignant hepatic tumours in childhood. Virchows Arch Pathol Anat 1985; 407: 387-405
15. Stringer M, Hennayke S, Howard E, Spitz L, Shafford E, Mieli-Vergani G. Improved outcome for children with hepatoblastoma. Brit J Surg 1995; 82: 386-391
16. Superina R, Bambini D, Filler R, Almond P, Geissler G. A new technique for resecting unresectable liver tumors. J Pediatr Surg 2000; 35: 1294-1299
17. Superina R, Bilik R. Results of liver transplantation in children with unresectable liver tumors. J Pediatr Surg 1996; 31: 835-839
18. Tagge E, Tagge D, Reyes J. Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: Impact on survival. J Pediatr Surg 1992; 27: 292-297
19. v. Schweinitz D, Byrd D, Hecker H, Weinel P, Bode U, Bürger D, Erttmann R, Harms D, Mildenberger H. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Eur J Cancer 1997; 33: 1243-1249
20. v. Schweinitz D, Faundez A, Teichmann B, Birnbaum T, Koch A, Hecker H, Glüer S, Fuchs J, Pietsch T. Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma. Int J Cancer 2000; 85: 151-159
21. v. Schweinitz D, Fuchs J, Glüer S, Pietsch T. The occurrence of liver growth factor in hepatoblastoma. Eur J Pediatr Surg 1998; 8: 133-136
22. v. Schweinitz D, Hecker H, Bürger D, Mildenberger H. Chirurgische Therapie von Hepatoblastomen im Kindesalter. Langenbecks Arch Chir 1995; 380: 315-320
23. v. Schweinitz D, Hecker H, Harms D. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma. J Pediatr Surg 1995; 30: 845-852
24. v. Schweinitz D, Hecker H, Schmidt von Arndt G, Harms D. Prognostic factors and staging system in childhood hepatoblastoma. Int J Cancer 1997; 74: 593-599